Mediterranean and MIND Diets for Neurodegeneration

Mediterranean and MIND Diets for Neurodegeneration

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Mediterranean and MIND Diets for Neurodegeneration</th>
</tr>
<tr>
<td class="label">Target Component</td>
<td>Standard Form</td>
</tr>
<tr>
<td class="label">Leafy greens</td>
<td>Salad, sauteed leaves</td>
</tr>
<tr>
<td class="label">Berries</td>
<td>Whole berries</td>
</tr>
<tr>
<td class="label">Nuts</td>
<td>Whole almonds/walnuts</td>
</tr>
<tr>
<td class="label">Whole grains</td>
<td>Dry rice, crusty bread</td>
</tr>
<tr>
<td class="label">Fish</td>
<td>Fillet pieces</td>
</tr>
<tr>
<td class="label">Legumes</td>
<td>Whole beans</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Score</td>
</tr>
<tr>
<td class="label">Mechanistic Clarity</td>
<td>8</td>
</tr>
<tr>
<td class="label">Clinical Evidence</td>
<td>8</td>
</tr>
<tr>
<td class="label">Preclinical Evidence</td>
<td>7</td>
</tr>
<tr>
<td class="label">Replication</td>
<td>8</td>
</tr>
<tr>
<td class="label">Effect Size</td>
<td>7</td>
</tr>
<tr>
<td class="label">Safety/Tolerability</td>
<td>9</td>
</tr>
<tr>
<td class="label">Biological Plausibility</td>
<td>8</td>
</tr>
<tr>
<td class="label">Actionability</td>
<td>9</td>
</tr>
</table>

Mediterranean and MIND Diets for Neurodegeneration

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Mediterranean and MIND Diets for Neurodegeneration</th>
</tr>
<tr>
<td class="label">Target Component</td>
<td>Standard Form</td>
</tr>
<tr>
<td class="label">Leafy greens</td>
<td>Salad, sauteed leaves</td>
</tr>
<tr>
<td class="label">Berries</td>
<td>Whole berries</td>
</tr>
<tr>
<td class="label">Nuts</td>
<td>Whole almonds/walnuts</td>
</tr>
<tr>
<td class="label">Whole grains</td>
<td>Dry rice, crusty bread</td>
</tr>
<tr>
<td class="label">Fish</td>
<td>Fillet pieces</td>
</tr>
<tr>
<td class="label">Legumes</td>
<td>Whole beans</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Score</td>
</tr>
<tr>
<td class="label">Mechanistic Clarity</td>
<td>8</td>
</tr>
<tr>
<td class="label">Clinical Evidence</td>
<td>8</td>
</tr>
<tr>
<td class="label">Preclinical Evidence</td>
<td>7</td>
</tr>
<tr>
<td class="label">Replication</td>
<td>8</td>
</tr>
<tr>
<td class="label">Effect Size</td>
<td>7</td>
</tr>
<tr>
<td class="label">Safety/Tolerability</td>
<td>9</td>
</tr>
<tr>
<td class="label">Biological Plausibility</td>
<td>8</td>
</tr>
<tr>
<td class="label">Actionability</td>
<td>9</td>
</tr>
</table>

The Mediterranean diet and the MIND diet are among the most studied dietary patterns in cognitive aging and neurodegenerative risk reduction.[@estruch2018][@morris2015] They are not single nutrients or short-term interventions; they are long-horizon exposure patterns that shift vascular risk, inflammatory tone, oxidative stress burden, gut-derived metabolites, insulin signaling, and synaptic resilience.[@scarmeas2006][@scarmeas2009][@lourida2013] In clinical practice, this matters because [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and atypical parkinsonian syndromes such as [corticobasal syndrome](/diseases/corticobasal-syndrome) and [progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy) usually evolve over years, and multi-pathway interventions are more plausible than single-target rescue.

The Mediterranean pattern emphasizes vegetables, legumes, whole grains, nuts, fish, and extra-virgin olive oil, with lower intake of red/processed meat and ultra-processed foods.[@estruch2018][@martnezlapiscina2013] The MIND pattern (Mediterranean-DASH Intervention for Neurodegenerative Delay) narrows this framework for brain outcomes by prioritizing leafy greens and berries while explicitly limiting butter, pastries, fried foods, and high-saturated-fat patterns.[@morris2015][@berendsen2018]

The strongest evidence base is still prevention and risk-modification rather than disease reversal.[@singh2014][@solfrizzi2020] However, for patients already living with neurodegeneration, these patterns remain clinically relevant because they can improve cardiometabolic comorbidity control, support bowel regularity, reduce inflammatory dietary load, and structure caregiver meal planning.[@cederholm2017][@volkert2019][@burgos2018] For CBS/PSP specifically, nutritional strategy must be adapted to dysphagia, motor limitations, and energy-balance instability.

Mechanistic Framework

The dietary signal is distributed across interacting pathways. A practical way to visualize mechanism is:

1) Neuroinflammation and Resolution Biology

Mediterranean-style eating patterns repeatedly associate with lower circulating inflammatory markers and better endothelial biology.[@dinu2018][@chrysohoou2004][@wahl2020] A central mechanism is replacement of saturated-fat dominant patterns with monounsaturated fat (olive oil), whole-food polyphenols, and marine fatty acids.[@piroddi2017][@ros2010] Unlike simple anti-inflammatory suppression, omega-3 availability also supports specialized pro-resolving mediators (SPMs), including resolvins and protectins, which help terminate chronic inflammatory signaling.[@calder2010][@bazan2018]

In neurodegeneration, chronic low-grade inflammation, microglial priming, and immune-metabolic dysfunction contribute to progression.[@heneka2015][@glass2010] Dietary modulation is not sufficient alone, but it can lower background inflammatory pressure and potentially improve tolerance of concurrent therapies.

2) Oxidative Stress and Mitochondrial Burden

Neuronal systems with high metabolic demand are vulnerable to oxidative damage. Polyphenol-rich foods, extra-virgin olive oil phenolics, nuts, and berry flavonoids provide a biochemical environment associated with reduced lipid peroxidation and improved redox balance.[@piroddi2017][@angeloni2017][@vauzour2017] The clinical implication is modest but meaningful: these diets likely reduce cumulative oxidative injury rather than creating acute symptomatic effects.

3) Vascular-Cognitive Coupling

Cognitive decline and parkinsonian disability are accelerated by vascular comorbidity. Mediterranean adherence is associated with lower hypertension, better lipid profile, lower major cardiovascular event rates, and improved endothelial function.[@estruch2018][@dinu2018][@buckland2019] Cerebral small-vessel disease and perfusion inefficiency are common co-pathologies in older patients with neurodegenerative syndromes. A vascular-protective diet may therefore protect cognition indirectly even when primary proteinopathy (amyloid/tau/synuclein) persists.

4) Insulin Resistance and Metabolic Signaling

Dietary patterns with high refined carbohydrate load and ultra-processed foods worsen insulin resistance and glycemic variability, both linked to cognitive decline trajectories.[@arnold2018][@craft2005] Mediterranean/MIND models improve insulin sensitivity markers in many cohorts, partly through higher fiber, lower glycemic load, and unsaturated-fat substitution.[@esposito2010] Because insulin signaling intersects with synaptic plasticity and [tau](/proteins/tau) phosphorylation pathways, metabolic control is mechanistically relevant to tauopathies and mixed dementias.[@arnold2018][@akter2011]

5) Gut-Brain Axis

Higher dietary fiber, legumes, and polyphenol diversity are associated with greater [microbiome](/entities/microbiome) diversity and favorable short-chain fatty acid production.[@de2016][@toribiomateas2021] These microbial products affect epithelial barrier function and systemic immune tone, creating one plausible route by which diet influences neuroinflammatory context.[@cryan2019] Evidence is associative more than interventional in neurodegeneration, but the directionality is biologically coherent.

Clinical Evidence Base

PREDIMED and Cognition-Relevant Findings

PREDIMED is the landmark randomized framework supporting Mediterranean-pattern outcomes, initially focused on cardiovascular prevention in high-risk adults.[@estruch2018] Subsequent analyses and substudies linked Mediterranean assignments (extra-virgin olive oil or mixed nuts) with better cognitive trajectories compared with low-fat control guidance.[@martnezlapiscina2013][@vallspedret2015] Cognitive analyses were not the original primary endpoint in early protocol design, so interpretation should remain careful; still, consistency across analyses strengthens plausibility.

MIND Diet Cohorts

The original MIND study reported a strong association between high adherence and lower incident Alzheimer's disease risk, with intermediate adherence still showing signal.[@morris2015] Follow-up observational cohorts replicated directionality for slower cognitive decline and lower dementia incidence, though effect sizes vary by population, adherence scoring, and confounder adjustment.[@berendsen2018][@agarwal2023][@hosking2019]

Systematic Reviews and Meta-Analyses

Meta-analytic syntheses generally find protective associations between Mediterranean-like adherence and cognitive outcomes, MCI risk, or dementia incidence.[@singh2014][@solfrizzi2020][@psaltopoulou2013] Key limitations include heterogeneous adherence tools, variable baseline diet quality, and residual confounding. Nonetheless, the aggregate evidence supports recommending these patterns as low-risk, high-coherence background interventions.

Alzheimer's Disease Context

In AD-focused datasets, higher Mediterranean/MIND adherence links to lower incident AD risk and slower decline in some cohorts.[@morris2015][@gu2011][@fart2010] Imaging studies suggest associations with reduced cortical atrophy burden and more favorable structural markers, though causality remains uncertain.[@mosconi2014] Dietary intervention should be framed as risk-modifying and supportive, not disease-modifying in the regulatory sense.

Parkinson's Disease and Related Syndromes

Several cohorts and meta-analytic work suggest Mediterranean-pattern adherence associates with lower PD risk and later PD onset, with possible benefit in non-motor burden.[@hillburns2014][@maraki2019][@petersson2016] Data quality is lower than in cardiovascular prevention and AD epidemiology, but mechanistic overlap (oxidative stress, inflammation, mitochondrial strain, vascular comorbidity) supports pragmatic use in PD care plans.

Evidence Gaps for CBS/PSP

There are no large RCTs dedicated to diet patterns in CBS/PSP. Extrapolation is required from broader neurodegenerative and geriatric nutrition evidence.[@cederholm2017][@burgos2018] Because dysphagia and axial motor dysfunction dominate disability in PSP/CBS, adaptation quality often matters more than theoretical nutrient perfection.

Nutrient-Level Interpretation Within Pattern-Based Care

Extra-Virgin Olive Oil (EVOO)

EVOO provides monounsaturated fats plus polyphenols (for example, hydroxytyrosol derivatives) associated with antioxidant and endothelial-supportive effects.[@piroddi2017][@angeloni2017] In practice, replacing butter/cream-heavy fats with EVOO is one of the highest-yield habit changes in caregiver-managed kitchens.

Marine Omega-3 (EPA/DHA)

Fish intake contributes EPA/DHA for membrane dynamics and inflammation-resolution biochemistry.[@calder2010][@bazan2018] Trial data on omega-3 supplements in established dementia are mixed, but dietary fish integration remains reasonable for cardiometabolic and anti-inflammatory pattern goals.[@yurkomauro2010][@quinn2010]

Leafy Greens and Folate-Rich Plants

Leafy vegetables deliver folate, carotenoids, vitamin K, nitrate, and polyphenols tied to slower cognitive aging in cohort work.[@morris2018][@samieri2013] For patients with chewing difficulty, pureed soups, finely chopped braises, and fortified green sauces can preserve intake without aspiration-prone textures.

Berries and Flavonoids

Berries are central in MIND scoring due to flavonoid density and repeated associations with cognitive resilience.[@devore2012][@whyte2018] Frozen berries can be blended safely into thickened yogurt preparations for dysphagic patients.

Legumes, Whole Grains, and Fiber

These foods lower glycemic volatility, improve satiety, and support microbiome metabolites.[@esposito2010][@de2016] In advanced motor disability, texture and fatigue often reduce intake; soft lentil stews, pressure-cooked beans, and smooth hummus variants are practical alternatives.

Nuts and Seeds

Nuts are associated with vascular and metabolic benefits, but whole nuts are aspiration hazards in dysphagia.[@casas2014] Use nut butters, finely milled nut powders, or emulsified sauces depending on swallow evaluation.

Practical Translation for CBS/PSP

Swallow-Safety First

For [progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy) and [corticobasal syndrome](/diseases/corticobasal-syndrome), diet quality must be subordinated to airway safety. Use speech-language pathology guidance and International Dysphagia Diet Standardisation Initiative (IDDSI) texture targets where available.[@cichero2017]

Core principles:

• Prefer moist, cohesive textures over crumbly solids.
• Eliminate mixed-consistency foods when aspiration risk is high.
• Use thickened liquids only when clinically indicated and monitored.
• Shift to energy-dense, smaller meals when fatigue limits intake.

Caregiver Workflow Model

A sustainable pattern requires routine, not culinary complexity:

Dysphagia-Adapted Mediterranean/MIND Food Matrix

Motor Impairment and Meal Access

CBS/PSP patients may lose hand dexterity and postural stability. Adaptive tableware (high-lip bowls, weighted utensils, anti-slip mats), upright supported seating, and reduced distraction during meals can materially improve intake reliability.

Dosing, Adherence, and Quantified Targets

Pattern-based nutrition is not pharmaceutical dosing, but quantified targets improve consistency:

• Leafy greens: at least 6 servings/week (MIND-aligned).[@morris2015]
• Other vegetables: daily.
• Berries: at least 2 servings/week (higher is acceptable if glucose tolerance allows).[@morris2015]
• Legumes: at least 3 servings/week.
• Whole grains: around 3 servings/day when tolerated.
• Fish: at least 1 serving/week minimum; 2-3 preferred.
• EVOO: principal culinary fat, typically 2-4 tablespoons/day depending on caloric goals.
• Red/processed meat: minimize.
• Fried/ultra-processed sweets: minimize to occasional use.

Safety, Contraindications, and Clinical Monitoring

Dietary interventions are generally safe, but neurodegenerative populations have specific risks.

1) Weight Loss and Frailty Risk

Mediterranean/MIND implementation can unintentionally reduce calories if families focus only on restriction messages. In advanced disease, this can worsen frailty and infection vulnerability. Track body weight at least weekly during transition.

2) Dysphagia and Aspiration

Aspiration pneumonia risk can dominate prognosis in PSP/CBS. Any coughing, wet voice, prolonged mealtime, or recurrent chest infection should trigger swallow reassessment.[@cichero2017]

3) Anticoagulation Considerations

Large abrupt changes in vitamin K intake can affect warfarin management. Consistency matters more than avoidance; coordinate INR monitoring when leafy-green intake changes significantly.

4) Renal and Gastrointestinal Limits

High-fiber shifts may worsen bloating or constipation in low-mobility patients if hydration is inadequate. Escalate fiber gradually and pair with bowel regimen planning.

5) Alcohol Guidance

Some Mediterranean frameworks include moderate wine. For neurodegenerative care, alcohol is optional and often best minimized, especially with gait instability, sleep fragmentation, or interacting sedative medications.

Combination Strategy With Other Interventions

Mediterranean/MIND nutrition should be layered with other low-risk supports rather than treated as a stand-alone therapy:

• [Exercise and lifestyle interventions](/therapeutics/exercise-lifestyle-interventions)
• Sleep/circadian stabilization
• Swallow therapy and aspiration prevention
• Cardiometabolic optimization (blood pressure, glucose, lipids)
• Medication simplification and adverse-effect review

Evidence Quality and 8-Domain Rubric

Domain Scoring (0-10 each)

Total: 64/80

Implementation Protocol (12-Week)

Weeks 1-2: Foundation

• Replace butter/cream-heavy cooking fats with EVOO.
• Add one daily vegetable-based meal component.
• Introduce one fish meal per week.
• Remove one high-frequency ultra-processed snack category.

Weeks 3-6: Pattern Consolidation

• Reach leafy-green target frequency.
• Add berry intake twice weekly (texture-adapted as needed).
• Increase legume frequency.
• Build a repeatable 7-day menu with caregivers.

Weeks 7-12: Personalization

• Adjust calories for weight trend.
• Adjust fiber/hydration for bowel pattern.
• Reassess swallowing safety and texture level.
• Align meal timing with medication and fatigue cycles.

Open Questions and Research Priorities

Interpreting Conflicting or Weak Signals

Even for highly cited patterns, clinicians should expect discordant findings across cohorts and intervention studies. Several factors can attenuate or obscure benefit:

When apparently negative trials are reviewed in this context, many are better interpreted as "underpowered to detect long-horizon modest effects" rather than proof of no biological impact.[@solfrizzi2020][@vauzour2017] This matters for clinical communication: patients should not be promised rapid symptomatic improvement. Instead, clinicians can frame Mediterranean/MIND adherence as a cumulative risk-pressure reduction strategy that complements pharmacologic care and rehabilitation.

Practical Meal Architecture for Neurodegenerative Care

Daily Plate Template

For caregivers, a repeatable template reduces decision fatigue. A practical Mediterranean/MIND-aligned day can be structured as:

• Breakfast: soft whole-grain porridge with berry puree and ground flax; yogurt if protein is low.
• Lunch: lentil or bean soup blended to required texture level, plus olive-oil-fortified vegetable puree.
• Dinner: flaky fish in thick herb sauce, mashed legumes, and soft greens.
• Snacks: nut butter with soft fruit puree; high-protein yogurt with olive-oil drizzle if weight maintenance is difficult.

Seven-Day Rotation (Caregiver-Optimized)

Day 1-2 (batch foundation):

• Prepare large volumes of blended tomato-legume base, leafy soup concentrate, and fish stock.
• Portion into labeled containers by texture level and date.

• Introduce berry-yogurt and tahini-herb sauces to avoid taste fatigue.
• Alternate fish with soft poultry or tofu to maintain protein diversity.

• Use a simple checklist: greens, legumes, fish, berries, EVOO, hydration.
• Address barriers from the week (shopping access, caregiver time, swallowing fluctuations).

• Track weight trend, stool pattern, meal completion rate, and any aspiration events.
• Adjust next-week textures and energy density accordingly.

Protein and Sarcopenia Prevention

A common failure mode in advanced neurodegenerative care is unintended protein deficit from over-restriction or meal incompletion. Mediterranean/MIND plans should include explicit protein targets, distributed across meals to reduce fatigue burden. Legumes, fish, yogurt, and eggs can usually meet this goal when texture is adapted. If oral intake remains inadequate, clinicians should escalate to oral nutrition support and multidisciplinary review rather than intensifying restrictive dietary rules.[@cederholm2017][@volkert2019][@burgos2018]

Hydration Strategy

Dehydration worsens orthostatic symptoms, constipation, delirium risk, and overall function in older adults. Dysphagic patients need structured fluid plans using the least restrictive safe consistency. Useful tactics include scheduled fluid rounds, thickened broth options, and hydration tracking sheets shared between family and clinical teams.[@cichero2017]

Cultural and Socioeconomic Adaptation

Mediterranean/MIND principles can be implemented with non-Mediterranean cuisines by preserving functional features:

• Plant-forward base
• Unsaturated fat predominance
• Regular fish or equivalent omega-3 sources
• High fiber diversity
• Limited ultra-processed and high-sugar foods

Trial Design Blueprint for CBS/PSP Nutrition Studies

To close current evidence gaps, future CBS/PSP studies should avoid generic nutrition trial designs and include disease-specific feasibility endpoints.

Proposed Study Features

• Population: probable PSP and clinically defined CBS, stratified by dysphagia status.
• Intervention: Mediterranean/MIND counseling plus caregiver meal-kit workflow and texture adaptation protocol.
• Comparator: standard nutritional advice.
• Duration: 12 months minimum, ideally 18-24 months.
• Primary endpoints: adherence score, aspiration-related events, weight stability, and patient-reported meal burden.
• Secondary endpoints: gait/fall metrics, caregiver strain, cognitive trajectories, inflammatory biomarkers.

Why Feasibility Endpoints Matter

In PSP/CBS, intervention success is often determined by implementation burden and safety rather than purely biochemical targets. Trials that ignore swallowing dynamics, caregiver workload, and meal completion rates risk false-negative conclusions even when the biological model is sound.

Biomarker Layering

An efficient design can include exploratory biomarker panels (for example, inflammatory markers, metabolomics, and neurodegeneration biomarkers) to identify responder profiles. Such work may clarify whether dietary adherence modifies disease environment in a way that could potentiate pharmacologic trials.

Conclusion

Mediterranean and MIND dietary patterns are among the most defensible nutritional strategies for neurodegenerative risk reduction and supportive care. Their strength is not a single mechanistic claim but convergent, moderate effects across inflammation resolution, vascular protection, metabolic regulation, and gut-brain signaling.[@estruch2018][@morris2015][@singh2014][@solfrizzi2020] For CBS/PSP, success depends on adaptation: swallow-safe texture engineering, caregiver workflow design, and active monitoring of weight, hydration, and aspiration risk. Implemented this way, diet becomes a durable systems-level intervention that supports both patient safety and long-term brain-health goals.

See Also

• [Mediterranean Diet for Neurodegeneration](/therapeutics/mediterranean-diet-neurodegeneration)
• [Omega-3 Fatty Acid Therapy for Neurodegeneration](/therapeutics/omega-3-fatty-acids-neurodegeneration)
• [Protective Strategies for CBS/PSP](/therapeutics/protective-strategies-cbs-psp)
• [CBS/PSP Daily Action Plan](/therapeutics/cbs-psp-daily-action-plan)
• [CBS/PSP Rehabilitation Guide](/therapeutics/cbs-psp-rehabilitation-guide)
• [Gut-Brain Axis and Tauopathy](/mechanisms/gut-brain-axis-tauopathy)

External Links

• [ClinicalTrials.gov search: MIND diet cognition](https://clinicaltrials.gov/search?term=MIND%20diet%20cognition)
• [ClinicalTrials.gov search: Mediterranean diet cognitive decline](https://clinicaltrials.gov/search?term=Mediterranean%20diet%20cognitive%20decline)
• [CurePSP](https://www.psp.org/)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: SIRT1
• [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: CYP46A1
• [Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation](/hypothesis/h-9e9fee95) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: HCRTR1/HCRTR2
• [Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SMPD1
• [Membrane Cholesterol Gradient Modulators](/hypothesis/h-9d29bfe5) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: ABCA1/LDLR/SREBF2
• [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: NLRP3, CASP1, IL1B, PYCARD
• [Blood-Brain Barrier SPM Shuttle System](/hypothesis/h-959a4677) — <span style="color:#81c784;font-weight:600">0.75</span> · Target: TFRC
• [Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — <span style="color:#81c784;font-weight:600">0.74</span> · Target: P2RY1 and P2RX7

Related Analyses:

• [Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) &#x1f504;
• [SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas](/analysis/analysis-SEAAD-20260402) &#x1f504;
• [APOE4 structural biology and therapeutic targeting strategies](/analysis/SDA-2026-04-01-gap-010) &#x1f504;
• [Senescent cell clearance as neurodegeneration therapy](/analysis/SDA-2026-04-02-gap-senescent-clearance-neuro) &#x1f504;
• [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) &#x1f504;